AI assistant
Sending…
DEXCOM INC — Director's Dealing 2021
Nov 30, 2021
30198_dirs_2021-11-29_b545bf84-e26b-4814-b782-4eb3d2380bda.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2021-11-03
Reporting Person: Collins Richard Alexander (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-03 | Common Stock | S | 1500 | $647.05 | Disposed | 7204 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 910 | Direct |
Footnotes
F1: This Form 4 is being filed late due to an inadvertent administrative oversight and not any error of the reporting person.
F2: Shares are held by the Richard A. Collins Revocable Trust, with respect to which the reporting person is a trustee.
More from DEXCOM INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Regulatory Filings
2026
May 28
Transaction in Own Shares
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Board/Management Information
2026
Mar 2
Director's Dealing
2026
Feb 26
Board/Management Information
2026
Feb 26
Director's Dealing
2026
Feb 17